For more than 40 years a goal that too often has proved elusive is a pharmaceutical defeat of the human immunodeficiency virus—HIV. And the thrust in recent years has emphasized bringing newer, stealthier weapons to the ...
A drug approved in 2019 for macular degeneration apparently caused rare retinal side effects because of its interactions with the human immune system, two new studies have concluded.
The explosive rise in tick-borne diseases in many parts of the United States over the last five decades represents a major public health threat that demands innovative solutions, warns a group of Yale scientists. In a new ...
Oct 18, 2023
0
48
Researchers at Penn Medicine have made a major advance in understanding the biology of a common, puzzling, and often fatal heart disorder, dilated cardiomyopathy (DCM), which features the enlargement of the heart and a progressive ...
Nov 3, 2021
0
154
A patient population at increased risk for severe COVID-19 may help researchers understand why some people develop long-term, persistent symptoms (long COVID) while others do not.
Sep 6, 2023
0
45
As the world has witnessed firsthand, SARS-CoV-2, the virus that causes COVID, is difficult to control because of its ability to rapidly mutate and produce many different variants. Scientists at Scripps Research have now ...
Aug 10, 2022
0
151
An experimental antibiotic is under development that is capable of neutralizing a wide range of drug-resistant, Gram-positive bacteria—pathogens that protect themselves in a slimy shield, called a biofilm, designed by nature ...
A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer ...
Mar 1, 2022
0
198
At least 5 million people in Germany suffer from liver disease. Fibrosis, the pathological proliferation of connective tissue, plays an important role in many complications of chronic liver problems. Activated hepatic stellate ...
Apr 27, 2022
0
74
Antibodies have drawn a spotlight over the past year and a half as scientists and lay people alike have asked how long the infection-fighting proteins persist in the face of a formidable enemy—a pandemic virus that has ...
